Annals of Oncology
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1ValeG3
via IFTTT
Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
▼
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
- ► Φεβρουαρίου (1350)
-
▼
Ιανουαρίου
(1400)
-
▼
Ιαν 21
(50)
- Haematological cancer: Cancer risks persist after ...
- Lung cancer: Anti-PD-L1 therapy: patient selection...
- Patient-reported outcomes in the evaluation of tox...
- CNS cancer: Breaking boundaries - IDH mutations in...
- Preablative stimulated thyroglobulin correlates to...
- Follicular thyroid carcinoma with NRAS Q61K and GN...
- (Secondary) solid tumors in thyroid cancer patient...
- Clinical Application of Antimicrobial Bone Graft S...
- Giant Cutaneous Leiomyosarcoma Originating From th...
- Biomechanical model for computing deformations for...
- Adrenal adenocarcinoma with Kartagener's syndrome:...
- Editorial: proton pump inhibitor-responsive oesoph...
- Editorial: proton pump inhibitor-responsive oesoph...
- [Determination of hyperregeneratory esophagopathy ...
- Scintigraphy in laryngopharyngeal and gastroesopha...
- Randomized comparison of the i-gel(TM) with the LM...
- Assessment of feeding and swallowing in children: ...
- Profiles of orofacial dysfunction in different dia...
- Recent Progress in the Research of Eosinophilic Es...
- Primary Small Cell Carcinoma of the Esophagus (PSC...
- [Collet-Sicard Syndrome due to Occipital Condyle F...
- Laryngeal Manifestations of Neurofibromatosis.
- Primary esophageal melanoma: Report of a case.
- Editorial: proton pump inhibitor-responsive oesoph...
- Editorial: proton pump inhibitor-responsive oesoph...
- [Determination of hyperregeneratory esophagopathy ...
- Scintigraphy in laryngopharyngeal and gastroesopha...
- Profiles of orofacial dysfunction in different dia...
- Hands-On Surgical Training Workshop: an Active Rol...
- Sunscreen Increasingly Overshadows Alternative Sun...
- IJMS, Vol. 17, Pages 141: An Overview of Direct So...
- Prevalence of benign focal liver lesions: ultrasou...
- Safety and tolerability of direct-acting anti-vira...
- Activated thyroid hormone promotes differentiation...
- Quality-of-life and performance status results fro...
- Risk of colorectal cancer after solid organ transp...
- Risk of late relapse or reinfection with hepatitis...
- Management of pancreatic cancer in the elderly
- Long-term outcome of endoscopic resection vs. surg...
- HEATR1 negatively regulates Akt to help sensitize ...
- Radioembolization Versus Chemoembolization (DEBDOX...
- Red blood cell transfusion is associated with furt...
- Lipid emulsions in the treatment and prevention of...
- Safety and tolerability of nafamostat mesilate and...
- Serum aminotransferases in nonalcoholic fatty live...
- Screening for viral hepatitis prior to rituximab c...
- Anal intercourse and fecal incontinence: Evidence ...
- Trends in black-white disparities in breast and co...
- Worldwide inverse association between gastric canc...
- Knockdown of autophagy inhibits infectious hepatit...
-
▼
Ιαν 21
(50)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Πέμπτη 21 Ιανουαρίου 2016
Quality-of-life and performance status results from the phase 3 RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου